Clinical Trial Update: A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth Hormone [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 single-dose trial of a long-acting growth hormone in children, assessing safety, pharmacokinetics and pharmacody…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency in Children
• Growth Hormone Disorder

Drugs mentioned

• Long-acting growth hormone (long-acting growth hormone)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children | Phase 2 | Status: COMPLETED